Literature DB >> 9093344

Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis: morphological differences on computed tomographic scans.

T Y Chan1, D M Hansell, M B Rubens, R M du Bois, A U Wells.   

Abstract

BACKGROUND: The purpose of this study was to identify morphological differences on the computed tomographic (CT) scan between cryptogenic fibrosing alveolitis (CFA) and the fibrosing alveolitis associated with systemic sclerosis (FASSc), and to examine their biological relevance.
METHODS: One hundred and seven patients with CFA (n = 55) or FASSc (n = 52) who had undergone thin section CT scanning were included. Multivariate analysis was used to identify morphological differences on the CT scans between lone CFA and FASSc, and to determine whether the pattern and distribution of disease on the CT scans were functionally significant (as judged by the lung transfer factor (TLCO), forced vital capacity (FVC), and arterial oxygen tension (PaO2)) or predictive of survival (independent of the type and extent of fibrosing alveolitis, age, sex, and smoking history).
RESULTS: Increasingly extensive disease on CT scans was associated with a coarser reticular pattern (increase in reticular score per percentage increase in disease extent = 0.06, 95% confidence interval (CI) 0.03 to 0.09, p < 0.0005) and increasing upper zone involvement (increase in ratio of upper zone to total disease per percentage increase in disease extent = 0.002, 95% CI 0.000 to 0.003, p < 0.04). Patients with CFA were characterised by a higher upper zone ratio (difference = 0.08, 95% CI 0.02 to 0.13, p < 0.004) and a weak trend towards a coarser reticular pattern (p = 0.09), independent of disease extent. Smokers with CFA had more upper zone involvement (difference = 0.11, 95% CI 0.05 to 0.16, p < 0.0005) and a coarser reticular pattern (difference in reticular score = 1.92, 95% CI 0.27 to 3.55, p < 0.02) than smokers with FASSc. The extent of disease on the CT scan was predictive of lung function impairment and survival but the pattern and distribution of disease were not.
CONCLUSIONS: Patients with CFA have relatively more upper zone involvement than those with FASSc independent of the extent of disease on the CT scan. This finding may result from smoking related damage but is not functionally significant.

Entities:  

Mesh:

Year:  1997        PMID: 9093344      PMCID: PMC1758507          DOI: 10.1136/thx.52.3.265

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  12 in total

1.  Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. The BAL Cooperative Group Steering Committee.

Authors:  R M Cherniack; T V Colby; A Flint; W M Thurlbeck; J Waldron; L Ackerson; T E King
Journal:  Am Rev Respir Dis       Date:  1991-10

2.  Sarcoidosis: correlation of extent of disease at CT with clinical, functional, and radiographic findings.

Authors:  N L Müller; J B Mawson; J R Mathieson; R Abboud; D N Ostrow; P Champion
Journal:  Radiology       Date:  1989-06       Impact factor: 11.105

3.  Observer variation in pattern type and extent of disease in fibrosing alveolitis on thin section computed tomography and chest radiography.

Authors:  C D Collins; A U Wells; D M Hansell; R A Morgan; J E MacSweeney; R M du Bois; M B Rubens
Journal:  Clin Radiol       Date:  1994-04       Impact factor: 2.350

4.  Determinants of survival in idiopathic pulmonary fibrosis.

Authors:  D A Schwartz; R A Helmers; J R Galvin; D S Van Fossen; K L Frees; C S Dayton; L F Burmeister; G W Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  1994-02       Impact factor: 21.405

5.  Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment.

Authors:  J Wiggins; B Strickland; M Turner-Warwick
Journal:  Respir Med       Date:  1990-09       Impact factor: 3.415

6.  Regional distribution of emphysema: correlation of high-resolution CT with pulmonary function tests in unselected smokers.

Authors:  J W Gurney; K K Jones; R A Robbins; G L Gossman; K J Nelson; D Daughton; J R Spurzem; S I Rennard
Journal:  Radiology       Date:  1992-05       Impact factor: 11.105

7.  The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis.

Authors:  A U Wells; D M Hansell; M B Rubens; P Cullinan; C M Black; R M du Bois
Journal:  Am Rev Respir Dis       Date:  1993-10

8.  Fibrosing alveolitis: CT-pathologic correlation.

Authors:  N L Müller; R R Miller; W R Webb; K G Evans; D N Ostrow
Journal:  Radiology       Date:  1986-09       Impact factor: 11.105

9.  Structural features of interstitial lung disease in systemic sclerosis.

Authors:  N K Harrison; A R Myers; B Corrin; G Soosay; A Dewar; C M Black; R M Du Bois; M Turner-Warwick
Journal:  Am Rev Respir Dis       Date:  1991-09

10.  Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.

Authors:  A U Wells; P Cullinan; D M Hansell; M B Rubens; C M Black; A J Newman-Taylor; R M Du Bois
Journal:  Am J Respir Crit Care Med       Date:  1994-06       Impact factor: 21.405

View more
  2 in total

Review 1.  Genetic predictors of systemic sclerosis-associated interstitial lung disease: a review of recent literature.

Authors:  Carmel J W Stock; Elisabetta A Renzoni
Journal:  Eur J Hum Genet       Date:  2018-02-23       Impact factor: 4.246

2.  Severity classification for idiopathic pulmonary fibrosis by using fuzzy logic.

Authors:  Agnaldo José Lopes; Domenico Capone; Roberto Mogami; Regina Serrão Lanzillotti; Pedro Lopes de Melo; José Manoel Jansen
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.